The bipolar depression electrical treatment trial (better): Design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase

Neural Plasticity

Volumn 2015, Issue , 2015, Pages

  Pereira Junior, Bernardo De Sampaio ^a,b   Tortella, Gabriel ^a,b   Lafer, Beny ^b   Nunes, Paula ^b   Benseñor, Isabela Martins ^a   Lotufo, Paulo Andrade ^a   Machado Vieira, Rodrigo ^b,c   Brunoni, André R ^a,b  

^a University Hospital   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BRAIN DERIVED NEUROTROPHIC FACTOR; CLONAZEPAM; LAMOTRIGINE; LEVOMEPROMAZINE; LITHIUM; MOOD STABILIZER; NEUROTROPHIN; QUETIAPINE; RISPERIDONE; SERTRALINE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DSM-5; EVOKED MUSCLE RESPONSE; EXECUTIVE FUNCTION; FEMALE; GENETIC POLYMORPHISM; HAMILTON DEPRESSION RATING SCALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NERVE EXCITABILITY; NEUROPSYCHOLOGICAL TEST; PILOT STUDY; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL; STROOP TEST; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT DURATION; TREATMENT FAILURE; WORKING MEMORY; YOUNG MANIA RATING SCALE; ADOLESCENT; AGED; CASE REPORT; CLINICAL TRIAL (TOPIC); PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84927144587     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2015/684025     Document Type: Article

References (73)

1. J. R. Geddes and D. J. Miklowitz, "Treatment of bipolar disorder, " The Lancet, vol. 381, no. 9878, pp. 1672-1682, 2013.
2. L. L. Judd, H. S. Akiskal, P. J. Schettler et al. , "The long-term natural history of the weekly symptomatic status of bipolar I disorder, " Archives of General Psychiatry, vol. 59, no. 6, pp. 530-537, 2002.
3. L. L. Judd, H. S. Akiskal, P. J. Schettler et al. , "A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder, " Archives of General Psychiatry, vol. 60, no. 3, pp. 261-269, 2003.
4. A. Henin, E. Mick, J. Biederman et al. , "Is psychopharmacologic treatment associatedwith neuropsychological deficits in bipolar youth? The Journal of Clinical Psychiatry, vol. 70, no. 8, pp. 1178-1185, 2009.
5. D. I. Velligan, P. J. Weiden, M. Sajatovic et al. , "The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness, " The Journal of Clinical Psychiatry, vol. 70, supplement 4, pp. 1-48, 2009
6. L. N. Yatham, S. H. Kennedy, S. V. Parikh et al. , "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for themanagement of patients with bipolar disorder: update 2013, " Bipolar Disorders, vol. 15, no. 1, pp. 1-44, 2013.
7. I. Pacchiarotti, D. J. Bond, R. J. Baldessarini et al. , "The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders, "TheAmerican Journal of Psychiatry, vol. 170, no. 11, pp. 1249-1262, 2013.
8. A. M. A. Nivoli, F. Colom, A. Murru et al. , "New treatment guidelines for acute bipolar depression: a systematic review, " Journal of Affective Disorders, vol. 129, no. 1-3, pp. 14-26, 2011.
9. L. Tondo, G. H. Vázquez, and R. J. Baldessarini, "Options for pharmacological treatment of refractory bipolar depression, " Current Psychiatry Reports, vol. 16, no. 2, article 431, 2014.
10. P. Sienaert, L. Lambrichts, A. Dols, and J. de Fruyt, "Evidencebased treatment strategies for treatment-resistant bipolar depression: a systematic review, " Bipolar Disorders, vol. 15, no. 1, pp. 61-69, 2013.
11. M. Mondino, D. Bennabi, E. Poulet, F. Galvao, J. Brunelin, and E. Haffen, "Can transcranial direct current stimulation (tDCS) alleviate symptoms and improve cognition in psychiatric disorders? The World Journal of Biological Psychiatry, vol. 15, no. 4, pp. 261-275, 2014.
12. B. N. Gaynes, S. W. Lloyd, L. Lux et al. , "Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis, " Journal of Clinical Psychiatry, vol. 75, no. 5, pp. 477-489, 2014.
13. Z. Nahas, F. A. Kozel, X. Li, B. And erson, and M. S. George, "Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy, " Bipolar Disorders, vol. 5, no. 1, pp. 40-47, 2003.
14. B. DellOsso, E. Mundo, N. DUrso et al. , "Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression, " Bipolar Disorders, vol. 11, no. 1, pp. 76-81, 2009.
15. R. B. Cohen, A. R. Brunoni, P. S. Boggio, and F. Fregni, "Clinical predictors associated with duration of repetitive transcranial magnetic stimulation treatment for remission in bipolar depression: a naturalistic study, " Journal of Nervous and Mental Disease, vol. 198, no. 9, pp. 679-681, 2010.
16. A. R. Brunoni, M. A. Nitsche, N. Bolognini et al. , "Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions, " Brain Stimulation, vol. 5, no. 3, pp. 175-195, 2012.
17. A. R. Brunoni, J. Amadera, B. Berbel, M. S. Volz, B. G. Rizzerio, and F. Fregni, "A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation, " The International Journal of Neuropsychopharmacology, vol. 14, no. 8, pp. 1133-1145, 2011.
18. M. A. Nitsche and W. Paulus, "Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation, " Journal of Physiology, vol. 527, part 3, pp. 633-639, 2000.
19. A. R. Brunoni, L. Valiengo, A. Baccaro et al. , "The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, rand omized, controlled trial, " JAMA Psychiatry, vol. 70, no. 4, pp. 383-391, 2013.
20. P. Shiozawa, F. Fregni, I. M. Benseñor et al. , "Transcranial direct current stimulation for major depression: an updated systematic review and meta-analysis, "The International Journal of Neuropsychopharmacology, vol. 17, no. 9, pp. 1443-1452, 2014.
21. C. K. Loo, A. Alonzo, D. Martin, P. B. Mitchell, V. Galvez, and P. Sachdev, "Transcranial direct current stimulation for depression: 3-week, rand omised, sham-controlled trial, " British Journal of Psychiatry, vol. 200, no. 1, pp. 52-59, 2012.
22. A. R. Brunoni, R. Ferrucci, M. Bortolomasi et al. , "Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder, " Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 1, pp. 96-101, 2011.
23. R. Ferrucci, M. Bortolomasi, M. Vergari et al. , "Transcranial direct current stimulation in severe, drug-resistant major depression, " Journal of Affective Disorders, vol. 118, no. 1-3, pp. 215-219, 2009.
24. U. G. Kalu, C. E. Sexton, C. K. Loo, and K. P. Ebmeier, "Transcranial direct current stimulation in the treatment of major depression: a meta-analysis, " Psychological Medicine, vol. 42, no. 9, pp. 1791-1800, 2012.
25. P. C. Gand iga, F. C. Hummel, and L. G. Cohen, "Transcranial DC stimulation (tDCS): a tool for double-blind shamcontrolled clinical studies in brain stimulation, " Clinical Neurophysiology, vol. 117, no. 4, pp. 845-850, 2006.
26. G. G. Ambrus, W. Paulus, and A. Antal, "Cutaneous perception thresholds of electrical stimulation methods: comparison of tDCS and tRNS, " Clinical Neurophysiology, vol. 121, no. 11, pp. 1908-1914, 2010.
27. M. A. Nitsche, K. Fricke, U. Henschke et al. , "Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans, "TheJournal of Physiology, vol. 553, no. 1, pp. 293-301, 2003.
28. T. A. Zanão, A. H. Moffa, P. Shiozawa, P. A. Lotufo, I. M. Benseñor, and A. R. Brunoni, "Impact of two or less missing treatment sessions on tdcs clinical efficacy: results froma factorial, rand omized, controlled trial in major depression, " Neuromodulation, vol. 17, no. 8, pp. 737-742, 2014.
29. T. N. Tombaugh, J. Kozak, and L. Rees, "Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming, " Archives of Clinical Neuropsychology, vol. 14, no. 2, pp. 167-177, 1999.
30. M. Regard, E. Strauss, and P. Knapp, "Childrens production on verbal and non-verbal fluency tasks, " Perceptual and Motor Skills, vol. 55, no. 3, part 1, pp. 839-844, 1982.
31. L. F. M. Malloy-Diniz, M. F. Cruz, V. M. Torres, and R. M. Cosenza, "Oteste de aprendizagem auditivo-verbal de Rey: normas para uma populacão Brasileira, " Revista Brasileira de Neurologia, vol. 3, no. 36, pp. 79-83, 2000.
32. D. Wechsler, Wechsler Adult Intelligence Sacale, The Psychological Corporation, San Antonio, Tex, USA, 3rd edition, 1997.
33. J. F. Goldberg and K. E. Burdick, Eds. , Cognitive Dysfunction in Bipolar Disorder: A Guide for Clinicians, American Psychiatric Press, Washington, DC, USA, 2008, Journal Affevtive Disorders, 2008.
34. B. Arts, N. Jabben, L. Krabbendam, and J. van Os, "Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives, " Psychological Medicine, vol. 38, no. 6, pp. 771-785, 2008.
35. L. J. Robinson, J. M. Thompson, P. Gallagher et al. , "Ameta-analysis of cognitive deficits in euthymic patients with bipolar disorder, " Journal of Affective Disorders, vol. 93, no. 1-3, pp. 105-115, 2006.
36. I. J. Torres, V. G. Boudreau, and L. N. Yatham, "Neuropsychological functioning in euthymic bipolar disorder: a metaanalysis, " Acta Psychiatrica Scand inavica, no. 434, pp. 17-26, 2007.
37. E. Bora, M. Yucel, and C. Pantelis, "Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives, " Journal of Affective Disorders, vol. 113, no. 1-2, pp. 1-20, 2009.
38. S. J. Allen and D. Dawbarn, "Clinical relevance of the neurotrophins and their receptors, " Clinical Science, vol. 110, no. 2, pp. 175-191, 2006.
39. B. S. Fernand es, C. S. Gama, K. Maria Ceresér et al. , "Brainderived neurotrophic factor as a state-marker ofmood episodes in bipolar disorders: a systematic review and meta-regression analysis, " Journal of Psychiatric Research, vol. 45, no. 8, pp. 995-1004, 2011.
40. I. Grand e, G. R. Fries, M. Kunz, and F. Kapczinski, "The role of BDNF as a mediator of neuroplasticity in bipolar disorder, " Psychiatry Investigation, vol. 7, no. 4, pp. 243-250, 2010.
41. A. B. M. Cunha, B. N. Frey, A. C. And reazza et al. , "Serumbrainderived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes, " Neuroscience Letters, vol. 398, no. 3, pp. 215-219, 2006.
42. R. Machado-Vieira, M. O. Dietrich, R. Leke et al. , "Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode, " Biological Psychiatry, vol. 61, no. 2, pp. 142-144, 2007.
43. G. S. de Oliveira, K. M. Ceresér, B. S. Fernand es et al. , "Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients, " Journal of Psychiatric Research, vol. 43, no. 14, pp. 1171-1174, 2009.
44. G. N. Pand ey, H. S. Rizavi, Y. Dwivedi, and M. N. Pavuluri, "Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response, " Journal of the American Academy of Child and Adolescent Psychiatry, vol. 47, no. 9, pp. 1077-1085, 2008.
45. R. T. de Sousa, M. T. van de Bilt, B. S. Diniz et al. , "Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study, " Neuroscience Letters, vol. 494, no. 1, pp. 54-56, 2011.
46. J. F. Tramontina, A. C. And reazza, M. Kauer-SantAnna et al. , "Brain-derived neurotrophic factor serum levels before and after treatment for acute mania, " Neuroscience Letters, vol. 452, no. 2, pp. 111-113, 2009.
47. A. R. Brunoni, A. H. Kemp, P. Shiozawa et al. , "Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system, " European Neuropsychopharmacology, vol. 23, no. 11, pp. 1530-1540, 2013.
48. U. Palm, Z. Fintescu, M. Obermeier et al. , "Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression, " Journal of Affective Disorders, vol. 150, no. 2, pp. 659-663, 2013.
49. A. H. Kemp, D. S. Quintana, M. A. Gray, K. L. Felmingham, K. Brown, and J. M. Gatt, "Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis, " Biological Psychiatry, vol. 67, no. 11, pp. 1067-1074, 2010.
50. C. M. M. Licht, E. J. C. De Geus, F. G. Zitman, W. J. G. Hoogendijk, R. Van Dyck, and B. W. J. H. Penninx, "Association between major depressive disorder and heart rate variability in the Netherland s study of depression and anxiety (NESDA), " Archives of General Psychiatry, vol. 65, no. 12, pp. 1358-1367, 2008.
51. A. R. Brunoni, A. H. Kemp, E. M. Dantas et al. , "Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs electric current therapy to treat depression clinical study, " International Journal of Neuropsychopharmacology, vol. 16, no. 9, pp. 1937-1949, 2013.
52. E. Brietzke, L. Stertz, B. S. Fernand es et al. , "Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder, " Journal of Affective Disorders, vol. 116, no. 3, pp. 214-217, 2009.
53. J.-M. Kim, R. Stewart, S.-W. Kim et al. , "Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders, " Biological Psychiatry, vol. 62, no. 5, pp. 423-428, 2007.
54. S. M. OBrien, P. Scully, L. V. Scott, and T. G. Dinan, "Cytokine profiles in bipolar affective disorder: focus on acutely ill patients, " Journal of Affective Disorders, vol. 90, no. 2-3, pp. 263-267, 2006.
55. Y.-M. Bai, T.-P. Su, S.-J. Tsai et al. , "Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/ euthymic/depressive states of bipolar disorder, " Journal of Affective Disorders, vol. 166, pp. 187-192, 2014.
56. I. E. Bauer, M. C. Pascoe, B. Wollenhaupt-Aguiar, F. Kapczinski, and J. C. Soares, "Inflammatory mediators of cognitive impairment in bipolar disorder, " Journal of Psychiatric Research, vol. 56, pp. 18-27, 2014.
57. A. R. Brunoni, R. Machado-Vieira, C. A. Zarate et al. , "Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, rand omized, controlled trial, " Psychopharmacology, vol. 231, no. 7, pp. 1315-1323, 2014.
58. F. S. Neves, L. Malloy-Diniz, M. A. Romano-Silva et al. , "The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities, " Journal of Affective Disorders, vol. 131, no. 1-3, pp. 307-311, 2011.
59. M. A. Ferreira, M. C. ODonovan, Y. A. Meng et al. , "Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder, "Nature Genetics, vol. 40, no. 9, pp. 1056-1058, 2008.
60. Y. Liu, R. C. Ho, and A. Mak, "Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patientswithmajor depressive disorder: a meta-analysis and meta-regression, " Journal of Affective Disorders, vol. 139, no. 3, pp. 230-239, 2012.
61. T. G. Schulze, S. D. Detera-Wadleigh, N. Akula et al. , "Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder, "Molecular Psychiatry, vol. 14, no. 5, pp. 487-491, 2009.
62. L. J. Scott, P. Muglia, X. Q. Kong et al. , "Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry, " Proceedings of the National Academy of Sciences of theUnited States of America, vol. 106, no. 18, pp. 7501-7506, 2009.
63. P. Sklar, J. W. Smoller, J. Fan et al. , "Whole-genome association study of bipolar disorder, " Molecular Psychiatry, vol. 13, no. 6, pp. 558-569, 2008.
64. Psychiatric GWAS Consortium Bipolar Disorder Working Group, "Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4, " Nature Genetics, vol. 43, no. 10, pp. 977-983, 2011.
65. C. J. Stagg, S. Bestmann, A. O. Constantinescu et al. , "Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex, " The Journal of Physiology, vol. 589, no. 23, pp. 5845-5855, 2011.
66. A. J. Levinson, L. T. Young, P. B. Fitzgerald, and Z. J. Daskalakis, "Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation, " Journal of Clinical Psychopharmacology, vol. 27, no. 5, pp. 493-497, 2007.
67. S. Grimm, J. Beck, D. Schuepbach et al. , "Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder, " Biological Psychiatry, vol. 63, no. 4, pp. 369-376, 2008.
68. M. S. George and G. Aston-Jones, "Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), " Neuropsychopharmacology, vol. 35, no. 1, pp. 301-316, 2010.
69. A. J. Gelenberg, M. E. Thase, R. E. Meyer et al. , "The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies, " Journal of Clinical Psychiatry, vol. 69, no. 10, pp. 1513-1528, 2008.
70. A. Baccaro, A. R. Brunoni, I. M. Bensenor, and F. Fregni, "Hypomanic episode in unipolar depression during transcranial direct current stimulation, " Acta Neuropsychiatrica, vol. 22, no. 6, pp. 316-318, 2010.
71. A. P. Arul-Anand am, C. Loo, and P. Mitchell, "Induction of hypomanic episode with transcranial direct current stimulation, " The Journal of ECT, vol. 26, no. 1, pp. 68-69, 2010.
72. A. R. Brunoni, L. Valiengo, T. Zanao, J. F. de Oliveira, I. M. Bensenor, and F. Fregni, "Manic psychosis after sertraline and transcranial direct-current stimulation, " The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 23, no. 3, pp. E4-E5, 2011.
73. V. Gálvez, A. Alonzo, D. Martin, P. B. Mitchell, P. Sachdev, and C. K. Loo, "Hypomania induction in a patient with bipolar II disorder by transcranial direct current stimulation (tDCS), " The Journal of ECT, vol. 27, no. 3, pp. 256-258, 2011.